Showing results (51-60 of 164) with videos related to
Sort By:
Pageof 17
Oncotarget|January 18, 2019
Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patientsPaola Montes, Martin Kerick, Mónica Bernal, et al.Human Immunology|March 26, 2008
Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosisPilar Garrido, Julia Almeida, Jose María Romero, et al.The Lancet. Oncology|July 24, 2010
Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 studyLucio Crinò, Eric Dansin, Pilar Garrido, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)Pilar Garrido, Javier de Castro, Ángel Concha, et al.Cancer Immunology, Immunotherapy : CII|November 10, 2019
Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progressionPaola Montes, Mónica Bernal, Laura N Campo, et al.Lung Cancer (Amsterdam, Netherlands)|March 12, 2015
Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC)Pilar Garrido, Walburga Engel-Riedel, Monika Serke, et al.Human Resources for Health|September 20, 2023
Gender inequity in the medical profession: the women doctors in Spain (WOMEDS) studyClaudia Santucci, Beatriz González López-Valcarcel, Cristina Avendaño-Solá, et al.Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 12, 2020
[Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Fernando López-Ríos, Luis Paz-Ares, Julián Sanz, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 26, 2022
New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyDolores Isla, Maria D Lozano, Luis Paz-Ares, et al.Cancer Investigation|March 29, 2017
Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07Nuria Viñolas, Pilar Garrido, Dolores Isla, et al.Pageof 17